Based on the Tenet Healthcare Corporation stock forecast from 10 analysts, the average analyst target price for Tenet Healthcare Corporation is USD 165.42 over the next 12 months. Tenet Healthcare Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Tenet Healthcare Corporation is Bullish , which is based on 9 positive signals and 3 negative signals. At the last closing, Tenet Healthcare Corporation’s stock price was USD 129.46. Tenet Healthcare Corporation’s stock price has changed by -5.30% over the past week, -9.87% over the past month and +70.90% over the last year.
No recent analyst target price found for Tenet Healthcare Corporation
No recent average analyst rating found for Tenet Healthcare Corporation
Company Overview Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas. Read Less
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms...Read More
Frequently Asked Questions About Tenet Healthcare Corporation (THC) Stock
Based on ratings from 10 analysts Tenet Healthcare Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 17 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on THC's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for THC is USD 165.42 over the next 12 months. The maximum analyst target price is USD 197 while the minimum anlayst target price is USD 112.
THC stock's Price/Earning ratio is 4.10.
Our analysis grades THC stock's Price / Earning ratio at B-. This means that THC stock's Price/Earning ratio is above 18% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this THC may be undervalued for its sector.
The last closing price of THC's stock was USD 129.46.
The most recent market capitalization for THC is USD 12.31B.
Based on targets from 10 analysts, the average taret price for THC is projected at USD 165.42 over the next 12 months.
This means that THC's stock price may go up by +27.78% over the next 12 months.
We can't find any ETFs which contains Tenet Healthcare Corporation's stock.
As per our most recent records Tenet Healthcare Corporation has 78,810 Employees.
Tenet Healthcare Corporation's registered address is 14201 Dallas Parkway, Dallas, TX, United States, 75254.
You can get more information about it from Tenet Healthcare Corporation's website at https://www.tenethealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Tenet Healthcare Corporation (THC) Stock
Based on ratings from 10 analysts Tenet Healthcare Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 17 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on THC's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for THC is USD 165.42 over the next 12 months. The maximum analyst target price is USD 197 while the minimum anlayst target price is USD 112.
THC stock's Price/Earning ratio is 4.10.
Our analysis grades THC stock's Price / Earning ratio at B-. This means that THC stock's Price/Earning ratio is above 18% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this THC may be undervalued for its sector.
The last closing price of THC's stock was USD 129.46.
The most recent market capitalization for THC is USD 12.31B.
Based on targets from 10 analysts, the average taret price for THC is projected at USD 165.42 over the next 12 months.
This means that THC's stock price may go up by +27.78% over the next 12 months.
We can't find any ETFs which contains Tenet Healthcare Corporation's stock.
As per our most recent records Tenet Healthcare Corporation has 78,810 Employees.
Tenet Healthcare Corporation's registered address is 14201 Dallas Parkway, Dallas, TX, United States, 75254.
You can get more information about it from Tenet Healthcare Corporation's website at https://www.tenethealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for THC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
